Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Takeda submits Japanese NDA for cetilistat

Oct. 31, 2012

E.U. approval for linagliptin as add-on therapy in type 2 diabetes

Oct. 30, 2012

ViaCyte receives grant to continue development of diabetes therapy

Oct. 30, 2012

FDA turns down request for appeal on NDA for vaginal gel in preterm birth

Oct. 29, 2012

New GPR119 receptor agonists disclosed by Arena Pharmaceuticals

Oct. 29, 2012

Chugai enters Japanese license agreement for CSG-452

Oct. 29, 2012

FDA accepts NDA filing for controlled-release misoprostol vaginal insert

Oct. 26, 2012

Prodrug formulated to deliver simvastatin to skeletal tissue

Oct. 26, 2012

SJT Molecular Research divulges new agents for metabolic syndrome

Oct. 26, 2012

Phase III trial of reparixin in pancreatic islet transplantation enrolls first patient

Oct. 25, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...